Stocks to buy

Ray Dalio’s hedge fund Bridgewater Associates, recently made moves listed in the article. These three stocks match his strategy, attracting Bridgewater Associates’ capital. Dalio’s choices transcend financial figures, embodying his belief in innovation, sustainability and connectivity’s transformative power. These stocks exemplify progress, reflecting his investment philosophy. The first one, leading the solar revolution, is poised to
In recent years, the argument against dual-class stock investment has heated up considerably. Some feel they should be outlawed completely. In March 2019, I argued that the problem isn’t the share structure but the people running these companies. The share structure doesn’t stand in the way of market-beating returns in the hands of reasonable management
At the start of August, cybersecurity company Fortinet (NASDAQ:FTNT) issued financial results that missed Wall Street’s revenue expectations. Worse, the company lowered its forward guidance. This sent FTNT stock down 25% in a single trading session, its worst single-day price drop ever. The demise of Fortinet has cast a cloud over the entire cybersecurity sector,
High-yield dividend stocks can provide investors with an extra cushion in difficult markets. After all, you continue to get paid even if share prices fall. Of course, the higher the yield the greater the risk overall. Many companies that pay above 5% are considered high-yield/high-risk. However, if you simply look for firms that have long histories of
When it comes to investing in dividend stocks, some investors focus mainly on yield. This can sometimes lead to investing too heavily in stocks that, while offering a high yield, could end up becoming dividend traps, whether from cutting/suspending their dividends, and/or from shares declining in value, outweighing the large payouts. Other investors focus on dividend
Biotech stocks may offer some of the most explosive opportunities on the market. For one, we have millions of baby boomers demanding better care. Two, there’s substantial demand for new innovative therapies, especially with gene editing. Three, multiple heavyweight companies are hunting for new drugs to keep their pipelines fresh with patent expirations nearing. Even
While high-growth stocks that are under $5 tend to be riskier than average, they can also provide aggressive investors with market-beating returns. Smaller companies in their earlier growth stages often fall into this low-price-per-share category. A stock price under $5 is commonplace for companies starting out and building their businesses. The key is identifying those